26 Mar 2012 – Press Release: IND opens for anti-Staphylococcal drug XF-73 and NIAID-funded US clinical trial begins
News
Monday March 26, 2012
26 Mar 2012 – Press Release: IND opens for anti-Staphylococcal drug XF-73 and NIAI...
Brighton, UK – Clinical stage pharmaceutical company Destiny Pharma today made two important announcements about its lead drug for the prevention of post-surgical Staphylococcal infections, XF-73. The drug has progressed […]